Cryosite Ltd (CTE) - Net Assets

Latest as of June 2025: AU$2.39 Million AUD ≈ $1.69 Million USD

Based on the latest financial reports, Cryosite Ltd (CTE) has net assets worth AU$2.39 Million AUD (≈ $1.69 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$19.46 Million ≈ $13.77 Million USD) and total liabilities (AU$17.07 Million ≈ $12.08 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Cryosite Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$2.39 Million
% of Total Assets	12.27%
Annual Growth Rate	-1.99%
5-Year Change	191.62%
10-Year Change	-29.28%
Growth Volatility	103.02

Cryosite Ltd - Net Assets Trend (2001–2025)

This chart illustrates how Cryosite Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Cryosite Ltd assets under control for the complete picture of this company's asset base.

Annual Net Assets for Cryosite Ltd (2001–2025)

The table below shows the annual net assets of Cryosite Ltd from 2001 to 2025. For live valuation and market cap data, see CTE stock market capitalisation.

Year	Net Assets	Change
2025-06-30	AU$2.39 Million ≈ $1.69 Million	+64.87%
2024-06-30	AU$1.45 Million ≈ $1.03 Million	-47.92%
2023-06-30	AU$2.78 Million ≈ $1.97 Million	+49.49%
2022-06-30	AU$1.86 Million ≈ $1.32 Million	+127.16%
2021-06-30	AU$819.23K ≈ $579.65K	+428.96%
2020-06-30	AU$154.88K ≈ $109.58K	+109.02%
2019-06-30	AU$-1.72 Million ≈ $-1.21 Million	-188.30%
2018-06-30	AU$1.94 Million ≈ $1.38 Million	-38.28%
2017-06-30	AU$3.15 Million ≈ $2.23 Million	-6.80%
2016-06-30	AU$3.38 Million ≈ $2.39 Million	-4.69%
2015-06-30	AU$3.54 Million ≈ $2.51 Million	-42.23%
2014-06-30	AU$6.14 Million ≈ $4.34 Million	-2.06%
2013-06-30	AU$6.26 Million ≈ $4.43 Million	+14.30%
2012-06-30	AU$5.48 Million ≈ $3.88 Million	+16.82%
2011-06-30	AU$4.69 Million ≈ $3.32 Million	+7.73%
2010-06-30	AU$4.35 Million ≈ $3.08 Million	+0.33%
2009-06-30	AU$4.34 Million ≈ $3.07 Million	+0.44%
2008-06-30	AU$4.32 Million ≈ $3.06 Million	+15.66%
2007-06-30	AU$3.74 Million ≈ $2.64 Million	+32.80%
2006-06-30	AU$2.81 Million ≈ $1.99 Million	+13.54%
2005-06-30	AU$2.48 Million ≈ $1.75 Million	-18.46%
2004-06-30	AU$3.04 Million ≈ $2.15 Million	+9.71%
2003-06-30	AU$2.77 Million ≈ $1.96 Million	-28.79%
2002-06-30	AU$3.89 Million ≈ $2.75 Million	+0.56%
2001-06-30	AU$3.87 Million ≈ $2.74 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Cryosite Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 82532900.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$3.54 Million	148.10%
Other Comprehensive Income	AU$32.00K	1.34%
Total Equity	AU$2.39 Million	100.00%

Cryosite Ltd Competitors by Market Cap

The table below lists competitors of Cryosite Ltd ranked by their market capitalization.

Company	Market Cap
Hamashbir 365 Holdings Ltd TA:MSBI	$39.80 Million
SKB Shutters Corporation Bhd KLSE:7115	$39.80 Million
Sumi Indo Kabel Tbk JK:IKBI	$39.81 Million
Microequities Asset Management Group Ltd AU:MAM	$39.81 Million
DPS Resources Bhd KLSE:7198	$39.70 Million
Obase Bilgisayar ve Danismanlik Hizmetleri Ticaret A.S. IS:OBASE	$39.68 Million
DP Aircraft I Limited LSE:DPA	$39.68 Million
M.J. International Co Ltd TW:8466	$39.67 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cryosite Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,449,000 to 2,389,000, a change of 940,000 (64.9%).
Net income of 1,884,000 contributed positively to equity growth.
Dividend payments of 976,000 reduced retained earnings.
Other comprehensive income increased equity by 32,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$1.88 Million	+78.86%
Dividends Paid	AU$976.00K	-40.85%
Other Comprehensive Income	AU$32.00K	+1.34%
Total Change	AU$-	64.87%

Book Value vs Market Value Analysis

This analysis compares Cryosite Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 23.50x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 11.04x to 23.50x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2001-06-30	AU$0.10	AU$1.15	x
2002-06-30	AU$0.10	AU$1.15	x
2003-06-30	AU$0.07	AU$1.15	x
2004-06-30	AU$0.08	AU$1.15	x
2005-06-30	AU$0.06	AU$1.15	x
2006-06-30	AU$0.06	AU$1.15	x
2007-06-30	AU$0.08	AU$1.15	x
2008-06-30	AU$0.09	AU$1.15	x
2009-06-30	AU$0.09	AU$1.15	x
2010-06-30	AU$0.09	AU$1.15	x
2011-06-30	AU$0.10	AU$1.15	x
2012-06-30	AU$0.12	AU$1.15	x
2013-06-30	AU$0.13	AU$1.15	x
2014-06-30	AU$0.13	AU$1.15	x
2015-06-30	AU$0.08	AU$1.15	x
2016-06-30	AU$0.07	AU$1.15	x
2017-06-30	AU$0.07	AU$1.15	x
2018-06-30	AU$0.04	AU$1.15	x
2019-06-30	AU$-0.04	AU$1.15	x
2020-06-30	AU$0.00	AU$1.15	x
2021-06-30	AU$0.02	AU$1.15	x
2022-06-30	AU$0.04	AU$1.15	x
2023-06-30	AU$0.06	AU$1.15	x
2024-06-30	AU$0.03	AU$1.15	x
2025-06-30	AU$0.05	AU$1.15	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cryosite Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 78.86%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 13.35%
• Asset Turnover: 0.73x
• Equity Multiplier: 8.15x
Recent ROE (78.86%) is above the historical average (52.29%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	-25.46%	-40584.71%	0.00x	1.05x	AU$-1.37 Million
2002	-31.47%	-265.51%	0.11x	1.12x	AU$-1.61 Million
2003	-42.24%	-61.49%	0.54x	1.27x	AU$-1.45 Million
2004	-31.26%	-45.39%	0.48x	1.45x	AU$-1.25 Million
2005	-25.03%	-20.99%	0.63x	1.88x	AU$-868.10K
2006	3.60%	2.47%	0.80x	1.82x	AU$-179.96K
2007	24.70%	19.54%	0.74x	1.71x	AU$549.15K
2008	10.35%	6.91%	0.89x	1.68x	AU$14.95K
2009	0.17%	0.12%	0.84x	1.69x	AU$-426.78K
2010	0.11%	0.08%	0.78x	1.76x	AU$-430.86K
2011	7.13%	5.20%	0.75x	1.84x	AU$-134.83K
2012	18.66%	13.18%	0.79x	1.78x	AU$474.41K
2013	19.95%	14.71%	0.75x	1.81x	AU$623.54K
2014	8.24%	5.51%	0.82x	1.82x	AU$-107.91K
2015	12.84%	4.74%	1.05x	2.57x	AU$100.73K
2016	8.95%	3.01%	1.04x	2.86x	AU$-35.36K
2017	-4.51%	-2.44%	0.59x	3.12x	AU$-456.97K
2018	-12.59%	-4.17%	0.76x	3.98x	AU$-439.04K
2019	0.00%	-7.14%	0.34x	0.00x	AU$-393.55K
2020	955.72%	16.59%	0.38x	151.75x	AU$1.46 Million
2021	79.66%	6.51%	0.46x	26.85x	AU$570.65K
2022	73.29%	11.60%	0.55x	11.55x	AU$1.18 Million
2023	50.65%	11.81%	0.53x	8.14x	AU$1.13 Million
2024	126.98%	14.59%	0.64x	13.60x	AU$1.70 Million
2025	78.86%	13.35%	0.73x	8.15x	AU$1.65 Million

Industry Comparison

This section compares Cryosite Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $268,307,083
Average return on equity (ROE) among peers: -38.88%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Cryosite Ltd (CTE)	AU$2.39 Million	-25.46%	7.15x	$39.72 Million
Australian Clinical Labs Ltd (ACL)	$177.76 Million	13.46%	2.34x	$256.90 Million
Bcal Diagnostics Ltd (BDX)	$-81.85K	0.00%	0.00x	$21.65 Million
Genetic Signatures Ltd (GSS)	$61.10 Million	-29.23%	0.10x	$14.14 Million
Genetic Technologies Ltd (GTG)	$18.96 Million	-46.47%	0.09x	$4.01 Million
Healius Ltd (HLS)	$1.76 Billion	0.38%	1.72x	$254.32 Million
Imagion Biosystems Ltd (IBX)	$4.68 Million	-209.71%	1.13x	$5.90 Million
Integral Diagnostics Ltd (IDX)	$373.05 Million	6.71%	1.25x	$585.79 Million
Inoviq Ltd (IIQ)	$10.44 Million	1.30%	0.08x	$32.37 Million
Microba Life Sciences Ltd (MAP)	$7.70 Million	-86.33%	0.40x	$32.75 Million

About Cryosite Ltd

AU:CTE Australia Diagnostics & Research

Market Cap

$39.72 Million

AU$56.13 Million AUD

Market Cap Rank

#22710 Global

#865 in Australia

Share Price

AU$1.15

Change (1 day)

+0.00%

52-Week Range

AU$0.66 - AU$1.30

All Time High

AU$1.30